Sharpening the focus on occupational safety and health in nanotechnology

Scandinavian Journal of Work, Environment and Health

Volumn 34, Issue 6, 2008, Pages 471-478

  Schulte, Paul ^a   Geraci, Charles ^a   Zumwalde, Ralph ^a   Hoover, Mark ^a   Castranova, Vincent ^a   Kuempel, Eileen ^a   Murashov, Vladimir ^a   Vainio, Harri ^b   Savolainen, Kai ^b  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

Author keywords

Engineering; Exposure; Hazard; Nanoparticle; Risk

Indexed keywords

NANOMATERIAL; NANOPARTICLE;

ENGINEERING; HEALTH RISK; NANOTECHNOLOGY; OCCUPATIONAL EXPOSURE; PARTICLE SIZE; SAFETY; WORKPLACE;

AEROSOL; AIR POLLUTION; ALGORITHM; ARTICLE; DISEASE SURVEILLANCE; HEALTH PROGRAM; HUMAN; INDUSTRIAL WORKER; NANOENGINEERING; NANOTECHNOLOGY; NONHUMAN; OCCUPATIONAL DISEASE; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; OCCUPATIONAL HEALTH; OCCUPATIONAL SAFETY; OCCUPATIONAL TOXICOLOGY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTECTIVE EQUIPMENT; RADIATION EXPOSURE; RECYCLING; RISK ASSESSMENT; RISK MANAGEMENT; STANDARDIZATION; TOXIN ANALYSIS; WORK ENVIRONMENT; AIR POLLUTANT; ANIMAL; ENVIRONMENTAL MONITORING; HEALTH SURVEY; METHODOLOGY; SAFETY; STANDARD;

AIR POLLUTANTS, OCCUPATIONAL; ALGORITHMS; ANIMALS; ENVIRONMENTAL MONITORING; HUMANS; NANOSTRUCTURES; NANOTECHNOLOGY; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HEALTH; POPULATION SURVEILLANCE; SAFETY MANAGEMENT;

EID: 61549132036     PISSN: 03553140     EISSN: 1795990X     Source Type: Journal    
DOI: 10.5271/sjweh.1292     Document Type: Article

References (60)

1. Feynman R. There's plenty of room at the bottom [Internet]. Pasadena (CA): California Institute of Technology (Caltech) [cited 6 August 2008]. Available at http://www.zyvex.com/nanotech/feynman.html.
2. Takenaka S, Karg D, Roth C, Schulz H, Ziesenis A, Heinzmann U, et al. Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ Health Perspect. 2001;109(suppl. 4):547-51.
3. Oberdörster G, Sharp Z, Atudorei V, Elder A, Gelein R, Lunts A, et al. Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J Toxicol Environ Health Part A. 2002;65:1531-43.
4. Bermudez E, Mangum JB, Wong BA, Asgharian B, Hext PM, Warheit DB, et al. Pulmonary responses of mice, rats, and hamsters to subchronic inhalation of ultrafine titanium dioxide particles. Toxicol Sci. 2004;77:347-57.
5. Lam CW, James JT, McCluskey R, Arepalli J, Hunter. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci. 2004;77:126-34.
6. Geiser M, Rothen-Rutishauser B, Kapp N, Schürch S, Kreyling W, Schulz H, et al. Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect. 2005;113(11):1555-60.
7. Oberdörster G, Oberdörster E, Oberdörster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect. 2005;113(7):823-39.
8. Shvedova AA, Kisin ER, Mercer R, Murray AR, Johnson VJ, Potapovich AI, et al. Unusual inflammatory and fibrogenic pulmonary responses to single walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol. 2005;289(5): L698-708.
9. Elder A, Gelein R, Silva V, Feikert T, Opanashuk L, Carter J, et al. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect. 2006;114:1172-78.
10. Mercer RR, Scabilloni JF, Wang L, Kisin ER, Murray AR, Schwegler-Berry D, et al. Alteration of deposition pattern and pulmonary response as a result of improved dispersion of aspirated single walled carbon nanotubes in a mouse model. Am J Physiol Lung Cell Mol Physiol. 2008;294:l87-97. doi: 10.1152/ajplung.00186.2007.
11. Dockery DW, Pope CA, Xu X, Spengler JD, Ware JH, Fay ME, et al. An association between air pollution and mortality in six U.S. cities. N Engl J Med. 1993;24:1753-59.
12. Oberdörster G. Pulmonary effects of ultrafine particles. Int Arch Occup Environ Health. 2001;74:1-8.
13. Donaldson K, Brown D, Clouter A, Duffin R, MacNee W, Renwick L, et al. The pulmonary toxicology of ultrafine particles. J Aerosol Med. 2002;15:213-20.
14. Maynard AD, Kuempel ED. Airborne nanostructured particles and occupational health. J Nanoparticles Res. 2005;7:587-614.
15. Gwinn MR, Vallyathan V. Nanoparticles: Health effects pros and cons. Environ Health Perspect. 2006;114:1818-25.
16. European Commission. List of activities in the FP7 calls for proposals of 2008 of direct relevance to nanotechnology [Internet]. Brussels: European Communities; 2007 [cited 13 February 2008]. Available from: ftp://ftp.cordis.europa.eu/pub/nanotechnology/docs/ call-2008_nano.pdf.
17. Kandliker M, Ramachandran G, Maynard A, Murdock B, Toscano WA. Health risk assessment for nanoparticles: a case for using expert judgement. J Nanoparticle Res. 2007;9:137-54.
18. Aitken RJ, Creely KS, Tran CL. Nanoparticles: an occupational hygiene review. Norwich (UK): HSE Books; 2004. 113 p. Health and safety executive research report, no 274.
19. National Institute for Occupational Safety and Health (NIOSH). Approaches to safe nanotechnology: an information exchange with NIOSH [Internet]. Cincinnati (OH): NIOSH; 2006. 43 p [cited 11 February 2008]. Available from: http://www.cdc.gov/niosh/topics/nanotech/safenano/.
20. Health and Safety Executive (HSE). Nanotechnology HSE information note: horizons scanning information. London: HSE; 2004; 4 p. Note No HSIN1.
21. European Commission. Nanosciences and nanotechnologies: an action plan for Europe 2005-2009 [Internet]. Brussels: European Communities; 2005 [cited 5 August 2008]. Available from: ftp://ftp.cordis.europa.eu/pub/ nanotechnology/docs/nano_com_en.pdf.
22. Boccuni F, Rondinone B, Petyx C, Lavicoli S. Potential occupational exposure to manufactured nanoparticles in Italy. J Clean Product. 2008;16(8-9):949-56.
23. Morawska L, Moore MR, Ristovski ZD. Health impacts of ultrafine particles. Canberra (Australia): Australian Department of the Environment and Heritage; 2004.
24. Nikula KJ, Snipes MB, Barr EB, Griffith WC, Henderson RF, Mauderly JL. Comparative pulmonary toxicities and carcinogenicities of chronically inhaled diesel exhaust and carbon black in F344 rats. Fundam Appl Toxicol. 1995;25:80-94.
25. Heinrich U, Fuhst R, Rittinghausen S, Creutzenberg O, Bellmann B, Koch W, et al. Chronic inhalation exposure of Wistar rats and two different strains of mice to diesel engine exhaust, carbon black, and titanium dioxide. Inhal Toxicol. 1995;7:533-56.
26. Li Z, Hulderman T, Salmen R, Chapman R, Leonard SS, Young SH, et al. Cardiovascular effects of pulmonary exposure to single-wall carbon nanotubes. Environ Health Perspect. 2007;115:377-82.
27. Porter AE, Gass M, Muller K, Skepper JN, Midgley P, Welland M. Direct imaging of single-walled carbon nanotubes in cells. Nat Nanotechnol. 2007;2:713-17.
28. Porter AE, Gass M, Muller K, Skepper JN, Midgley P, Welland M. Visualizing the uptake of C60 to the cytoplasm and nucleus of human monocyte-derived macrophage cells using energy- filtered transmission electron microscopy and electron tomography. Environ Sci Technol. 2007;41(8):3012-17.
29. Oberdörster G, Sharp Z, Atudorei V, Elder A, Gelein R, Kreyling W, et al. Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol. 2004;16(6-7):437-45.
30. Ryman-Rasmussen JP, Riviere JE, Monteiro-Riviere NA. Penetration of intact skin by quantum dots with diverse physiochemical properties. Toxicol Sci. 2006;91(1):159-65.
31. Institut de Recherche Robert-Sauvé en Santé du Travail (IRSST). Nanoparticles: actual knowledge about occupational health and safety risks and prevention measures [Internet]. Montreal (Canada): IRSST; 2006 [cited 11 February, 2008]. Studies and research projects R-470. Available from: http://www.irsst.qc.ca/files/documents/PubIRSST/ R-470.pdf.
32. British Standards Institute (BSI). Nanotechnologies part 2: guide to safe handling and disposal of manufactured nanomaterials. Bristol (United Kingdom): BSI; 2007. PD6699-2:200-1.
33. Pylkkänen L, Alenius H, Tuomi T, Savolainen K. The effect of nanoparticles on the expression of mRNA and proteins of chemokines and cytokines in inflammatory cells in the lungs. The Sixth Princess Chulabhorn International Science Congress; 25-29 November 2007, Bangkok, (Thailand). Bangkok: Amarin Printing and Publishing Public Company Ltd; 2007. p 237-41.
34. Poland CA, Duffin R, Kinloch I, Maynard A, Wallace WH, Seaton A, et al. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol. 2008;3:423-28. doi: 10.1038/nnano.2008.111.
35. Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nanolevel. Science. 2006;311(5761):622-27.
36. Limbach LK, Widmer M, Husmann F, Gehr P, Blank F, Riediker M, et al. Exposure of engineered nanoparticles to human lung epithelial cells: influence of chemical composition and catalytic activity on oxidative stress. Environ Sci Technol. 2007;41:4158-63.
37. Oberdörster G, Ferin J, Lehnert BE. Correlation between particle- size, in-vivo particle persistence, and lung injury. Environ Health Perspect. 1994;102(S5):173-9.
38. Driscoll KE. Role of inflammation in the development of rat lung tumors in response to chronic particle exposure. In: Mauderly JL, McCunney RJ, editors. Particle overload in the rat lung and lung cancer: implications for human risk assessment. Philadelphia (PA): Taylor & Francis; 1996. p 139-52.
39. Duffin R, Tran L, Brown D, Stone V, Donaldson K. Proinflammogenic effects of low-toxicity and metal nanoparticles in vivo and in vitro: highlighting the role of particle surface area and surface reactivity. Inhal Toxicol. 2007;19(10):849-56.
40. Kuempel ED, Geraci CL, Schulte PA. Risk assessment and research needs for nanomaterials: an examination of data and information from current studies. In: Kuempel E, Geraci C, Schulte P, editors. NATO advanced research workshop on nanotechnology: toxicological issues and environmental security. Netherlands: Spinger Netherlands; 2007. p 119-45.
41. 2. Inhal Toxicol. 2007;19 suppl 1:205-12.
42. Renwick LC, Brown D, Clouter A, Donaldson K. Increased inflammation and altered macrophage chemotactic responses caused by two ultrafine particle types. Occup Environ Med. 2004;61(5):442-7.
43. International Organization for Standardization (ISO). Workplace atmospheres - ultrafine, nanoparticle, and nano-structured aerosols - inhalation, exposure characterization and assessment. Geneva: ISO; 2007. p 34. ISO/TR 27628:2007.
44. Maynard AD, Aitken RJ. Assessing exposure to airborne nanomaterials: current abilities and future requirements. Nanotoxicology. 2007;1:26-41.
45. Mazzuckelli LF, Methner MM, Birch ME, Evans DE, Ku BK, Crouch K, et al. Identification and characterization of potential sources of worker exposure to carbon nanofibers during polymer composite laboratory operations. J Occup Environ Hyg. 2007;4(12):D125-30.
46. Maynard AD, Baron PA, Foley M, Shvedova AA, Kisin ER, Castranova V. Exposure to carbon nanotube material: aerosol release during the handling of unrefined single walled carbon nanotube material. J Toxicol Environ Health. 2004;67(1):87-107.
47. Schulte PA, Geraci CL, Zumwalde R, Hoover M, Kuempel E. Occupational risk management of engineered nanoparticles. J Occup Environ Hyg. 2008;5:239-49.
48. Organization for Economic Co-operation and Development (OECD). Report of the OECD workshop on the safety of manufactured nanomaterials: building co-operation, co-ordination and communication, Washington DC, United States, 7th-9th December 2005. Paris: OECD; 2006. OECD environment health and safety publications series on the safety of manufactured nanomaterials, no 1.
49. Hinds WC. Aerosol technology: properties, behavior, and measurement of airborne particles. 2nd ed. New York (NY): Wiley Intersciences; 1999.
50. Halperin WE. The role of surveillance in the hierarchy of prevention. Am J Ind Med. 1996;29:321-3.
51. Harber P, Conlon C, McCunney RJ. Occupational medical surveillance. In: McCunney RJ, editor. A practical approach to occupational and environmental medicine. Philadelphia (PA): Lippincott, Williams, and Wilkins; 2003. p 582-99.
52. Wegman DH. Hazard surveillance. In: Halperin W, Baker EL, Monson RR, editors. Public health surveillance. New York (NY): VanNostrand Reinhold; 1992. p 42-75.
53. Schulte PA, Trout D, Zumwalde RD, Kuempel E, Geraci CL, Castranova V, et al. Options for occupational health surveillance of workers potentially exposed to engineered nanoparticles: state of the science. J Occup Environ Med. 2008;50(5):517-26.
54. Schulte PA, Kaye WE. Exposure registries. Arch Environ Health. 1988;43:155-61.
55. Kauppinen T, Vincent R, Liukkonen T, Grzebyk M, Kauppinen A, Welling I, et al. Occupational exposure to inhalable wood dust in the member states of the European Union. Ann Occup Hyg. 2006;50:549-61.
56. Zhang Q, Kusaka Y, Donaldson K. Comparative pulmonary responses caused by exposure to standard cobalt and ultrafine cobalt. J Occup Health. 2000;42:179-84.
57. Zhang Q, Kusaka Y, Zhu X, Sato K, Mo Y, Kluz T, et al. Comparative toxicity of standard nickel and ultrafine nickel in lung after intratracheal instillation. J Occup Health. 2003;45:23-30.
58. Kuempel ED, Tran CL, Castranova V, Bailer AJ. Lung dosimetry and risk assessment of nanoparticles: evaluating and extending current models in rats and humans. Inhal Toxicol. 2006;18:717-24.
59. Takagi A, Hirose A, Nishimura T, Fukumori N, Ogata A, Ohashi N, et al. Induction of mesothelioma in p53+/- mouse by intraperitoneal application of multi-wall carbon nanotube. J Toxicol Sci. 2008;33(1):105-11.
60. Commission of the European Communities. Communication from the Commission to the European Parliament, the Council and the European Economic and Social Committee: regulatory aspects of nanomaterials. Brussels: Commission of the European Communities; 2008.